Form 8K Kineta Inc For: 1 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kineta Inc (KANT)
Kineta Inc stock price live, this page displays OTC KANT stock exchange data. View the KANT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kineta Inc real time stock price chart below.
What Is the Kineta Inc Stock Price Today?
The Kineta Inc stock price today is 0.3361.
What Is the Stock Symbol for Kineta Inc?
The stock symbol for Kineta Inc is ""KANT.""
What Stock Exchange Does Kineta Inc Trade On?
Kineta Inc is listed and trades on the OTC Markets stock exchange.
Is Kineta Inc a Good Stock to Buy?
Determining whether Kineta Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KANT quote. (ISIN: US49461C1027)
What Is the Kineta Inc Stock Price Today?
The Kineta Inc stock price today is 0.3361.
What Is the Stock Symbol for Kineta Inc?
The stock symbol for Kineta Inc is ""KANT.""
What Stock Exchange Does Kineta Inc Trade On?
Kineta Inc is listed and trades on the OTC Markets stock exchange.
Is Kineta Inc a Good Stock to Buy?
Determining whether Kineta Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KANT quote. (ISIN: US49461C1027)
OTC Markets
Currency in USD
0.3361
+0.0461(+15.90%)
Closed·
Fair Value
An estimate of a Kineta's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3041
0.3370
52 wk Range
0.1806
1.1500
Showing Kineta historical data. For real-time data please try another search
Fair Value
An estimate of a Kineta's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.30410.3370
52 wk Range
0.18061.1500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KANT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Kineta's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
- Kineta appoints new accounting firm amid concerns
- Investing.com
- TuHURA Biosciences completes Kineta acquisition
- Investing.com
Pro
- Form 8K Kineta Inc For: 1 July
- Investing.com
- TuHURA Biosciences completes Kineta acquisition
- Investing.com
Pro - KVA12123 shows promise in VISTA-101 trial
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Kineta Inc Company Profile
Kineta, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies that transform patients’ lives in the United States. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, renal cell carcinoma, head and neck, renal cell, and colorectal cancers. It also developing anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. It has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., Merck &Co., Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. formerly known as Yumanity Therapeutics, Inc. and changed its name to Kineta, Inc., in December 2016. The company was incorporated in 2006 and is headquartered in Mercer Island, Washington. As of June 30, 2025, Kineta, Inc. operates as a subsidiary of TuHURA Biosciences, Inc.
Compare KANT to Peers and Sector
Metrics to compare | KANT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKANTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −0.6x | −0.5x | |
PEG Ratio | −0.01 | 0.00 | 0.00 | |
Price/Book | −0.3x | 2.2x | 2.6x | |
Price / LTM Sales | - | 4.3x | 3.2x | |
Upside (Analyst Target) | - | 167.9% | 42.0% | |
Fair Value Upside | Unlock | 8.3% | 6.6% | Unlock |
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-0.13 / --
Revenue / Forecast
-- / --
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.